NeuBase Therapeutics Inc
:NBSE
NeuBase Therapeutics Inc Stock, :NBSE
350 Technology Drive, Suite 421, Pittsburgh, Pennsylvania 15219
United States of America
Phone: +1.412.763.3350
Number of Employees:
Description
NeuBase Therapeutics is a pre-clinical stage biopharmaceutical company that develops gene silencing therapies with its synthetic antisense oligonucleotides. It also provides a platform that focuses on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy, and Familial Parkinson's Disease, among others.